Literature DB >> 33658025

Automated detection of lung nodules and coronary artery calcium using artificial intelligence on low-dose CT scans for lung cancer screening: accuracy and prognostic value.

Jordan Chamberlin1, Madison R Kocher1, Jeffrey Waltz1, Madalyn Snoddy1, Natalie F C Stringer1, Joseph Stephenson1, Pooyan Sahbaee2, Puneet Sharma2, Saikiran Rapaka2, U Joseph Schoepf1, Andres F Abadia1, Jonathan Sperl2, Phillip Hoelzer2, Megan Mercer1, Nayana Somayaji1, Gilberto Aquino1, Jeremy R Burt3,4.   

Abstract

BACKGROUND: Artificial intelligence (AI) in diagnostic radiology is undergoing rapid development. Its potential utility to improve diagnostic performance for cardiopulmonary events is widely recognized, but the accuracy and precision have yet to be demonstrated in the context of current screening modalities. Here, we present findings on the performance of an AI convolutional neural network (CNN) prototype (AI-RAD Companion, Siemens Healthineers) that automatically detects pulmonary nodules and quantifies coronary artery calcium volume (CACV) on low-dose chest CT (LDCT), and compare results to expert radiologists. We also correlate AI findings with adverse cardiopulmonary outcomes in a retrospective cohort of 117 patients who underwent LDCT.
METHODS: A total of 117 patients were enrolled in this study. Two CNNs were used to identify lung nodules and CACV on LDCT scans. All subjects were used for lung nodule analysis, and 96 subjects met the criteria for coronary artery calcium volume analysis. Interobserver concordance was measured using ICC and Cohen's kappa. Multivariate logistic regression and partial least squares regression were used for outcomes analysis.
RESULTS: Agreement of the AI findings with experts was excellent (CACV ICC = 0.904, lung nodules Cohen's kappa = 0.846) with high sensitivity and specificity (CACV: sensitivity = .929, specificity = .960; lung nodules: sensitivity = 1, specificity = 0.708). The AI findings improved the prediction of major cardiopulmonary outcomes at 1-year follow-up including major adverse cardiac events and lung cancer (AUCMACE = 0.911, AUCLung Cancer = 0.942).
CONCLUSION: We conclude the AI prototype rapidly and accurately identifies significant risk factors for cardiopulmonary disease on standard screening low-dose chest CT. This information can be used to improve diagnostic ability, facilitate intervention, improve morbidity and mortality, and decrease healthcare costs. There is also potential application in countries with limited numbers of cardiothoracic radiologists.

Entities:  

Keywords:  Artificial intelligence; Cardiothoracic imaging; Convolutional neural networks; Coronary artery disease; Deep learning; Lung cancer screening

Mesh:

Substances:

Year:  2021        PMID: 33658025      PMCID: PMC7931546          DOI: 10.1186/s12916-021-01928-3

Source DB:  PubMed          Journal:  BMC Med        ISSN: 1741-7015            Impact factor:   8.775


  31 in total

1.  ACR-STR practice parameter for the performance and reporting of lung cancer screening thoracic computed tomography (CT): 2014 (Resolution 4).

Authors:  Ella A Kazerooni; John H M Austin; William C Black; Debra S Dyer; Todd R Hazelton; Ann N Leung; Michael F McNitt-Gray; Reginald F Munden; Sudhakar Pipavath
Journal:  J Thorac Imaging       Date:  2014-09       Impact factor: 3.000

2.  Coronary artery calcium score on low-dose computed tomography for lung cancer screening.

Authors:  Teresa Arcadi; Erica Maffei; Nicola Sverzellati; Cesare Mantini; Andrea I Guaricci; Carlo Tedeschi; Chiara Martini; Ludovico La Grutta; Filippo Cademartiri
Journal:  World J Radiol       Date:  2014-06-28

3.  Prediction of coronary heart disease using risk factor categories.

Authors:  P W Wilson; R B D'Agostino; D Levy; A M Belanger; H Silbershatz; W B Kannel
Journal:  Circulation       Date:  1998-05-12       Impact factor: 29.690

4.  Machine Learning/Deep Neuronal Network: Routine Application in Chest Computed Tomography and Workflow Considerations.

Authors:  Andreas M Fischer; Basel Yacoub; Rock H Savage; John D Martinez; Julian L Wichmann; Pooyan Sahbaee; Sasa Grbic; Akos Varga-Szemes; U Joseph Schoepf
Journal:  J Thorac Imaging       Date:  2020-05       Impact factor: 3.000

5.  Major risk factors as antecedents of fatal and nonfatal coronary heart disease events.

Authors:  Philip Greenland; Maria Deloria Knoll; Jeremiah Stamler; James D Neaton; Alan R Dyer; Daniel B Garside; Peter W Wilson
Journal:  JAMA       Date:  2003-08-20       Impact factor: 56.272

Review 6.  27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 3. Spectrum of risk factors for coronary heart disease.

Authors:  R C Pasternak; S M Grundy; D Levy; P D Thompson
Journal:  J Am Coll Cardiol       Date:  1996-04       Impact factor: 24.094

7.  Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers.

Authors:  Nanda Horeweg; Ernst Th Scholten; Pim A de Jong; Carlijn M van der Aalst; Carla Weenink; Jan-Willem J Lammers; Kristiaan Nackaerts; Rozemarijn Vliegenthart; Kevin ten Haaf; Uraujh A Yousaf-Khan; Marjolein A Heuvelmans; Erik Thunnissen; Matthijs Oudkerk; Willem Mali; Harry J de Koning
Journal:  Lancet Oncol       Date:  2014-10-01       Impact factor: 41.316

8.  Assessment of radiologist performance in the detection of lung nodules: dependence on the definition of "truth".

Authors:  Samuel G Armato; Rachael Y Roberts; Masha Kocherginsky; Denise R Aberle; Ella A Kazerooni; Heber Macmahon; Edwin J R van Beek; David Yankelevitz; Geoffrey McLennan; Michael F McNitt-Gray; Charles R Meyer; Anthony P Reeves; Philip Caligiuri; Leslie E Quint; Baskaran Sundaram; Barbara Y Croft; Laurence P Clarke
Journal:  Acad Radiol       Date:  2009-01       Impact factor: 3.173

9.  Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement.

Authors:  Virginia A Moyer
Journal:  Ann Intern Med       Date:  2014-03-04       Impact factor: 25.391

10.  Feasibility of lung cancer prediction from low-dose CT scan and smoking factors using causal models.

Authors:  Vineet K Raghu; Wei Zhao; Jiantao Pu; Joseph K Leader; Renwei Wang; James Herman; Jian-Min Yuan; Panayiotis V Benos; David O Wilson
Journal:  Thorax       Date:  2019-03-12       Impact factor: 9.102

View more
  6 in total

1.  Pulmonary Nodule Clinical Trial Data Collection and Intelligent Differential Diagnosis for Medical Internet of Things.

Authors:  Weijia Wu; Lizhong Gu; Yuefeng Zhang; Xianping Huang; Weihe Zhou
Journal:  Contrast Media Mol Imaging       Date:  2022-05-26       Impact factor: 3.009

Review 2.  The Future of Lung Cancer Screening: Current Challenges and Research Priorities.

Authors:  Amna Burzic; Emma L O'Dowd; David R Baldwin
Journal:  Cancer Manag Res       Date:  2022-02-16       Impact factor: 3.989

3.  Application of AI and IoT in Clinical Medicine: Summary and Challenges.

Authors:  Zhao-Xia Lu; Peng Qian; Dan Bi; Zhe-Wei Ye; Xuan He; Yu-Hong Zhao; Lei Su; Si-Liang Li; Zheng-Long Zhu
Journal:  Curr Med Sci       Date:  2021-12-22

4.  Tumor burden of lung metastases at initial staging in breast cancer patients detected by artificial intelligence as a prognostic tool for precision medicine.

Authors:  Madison R Kocher; Jordan Chamberlin; Jeffrey Waltz; Madalyn Snoddy; Natalie Stringer; Joseph Stephenson; Jacob Kahn; Megan Mercer; Dhiraj Baruah; Gilberto Aquino; Ismail Kabakus; Philipp Hoelzer; Pooyan Sahbaee; U Joseph Schoepf; Jeremy R Burt
Journal:  Heliyon       Date:  2022-02-15

5.  Lung Cancer Nodules Detection via an Adaptive Boosting Algorithm Based on Self-Normalized Multiview Convolutional Neural Network.

Authors:  Adeel Khan; Irfan Tariq; Haroon Khan; Sifat Ullah Khan; Nongyue He; Li Zhiyang; Faisal Raza
Journal:  J Oncol       Date:  2022-09-26       Impact factor: 4.501

Review 6.  Radiation-Induced Lung Injury-Current Perspectives and Management.

Authors:  Mandeep Singh Rahi; Jay Parekh; Prachi Pednekar; Gaurav Parmar; Soniya Abraham; Samar Nasir; Rajamurugan Subramaniyam; Gini Priyadharshini Jeyashanmugaraja; Kulothungan Gunasekaran
Journal:  Clin Pract       Date:  2021-07-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.